HighTower Advisors’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

HighTower Advisors’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-35,560	Closed	-$355K	–	3586
2022 Q3	$355K	Hold	35,560	–	–	﹤0.01%	2238
2022 Q2	$348K	Sell	35,560 -5,000	-12%	-$49K	﹤0.01%	2263
2022 Q1	$397K	Hold	40,560	–	–	﹤0.01%	2337
2021 Q4	$390K	Hold	40,560	–	–	﹤0.01%	2323
2021 Q3	$397K	Hold	40,560	–	–	﹤0.01%	2222
2021 Q2	$390K	Buy	+40,560	New	+$396K	﹤0.01%	2194

Other funds holding MSAC

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

HighTower Advisors's MSAC Position: Q4 2022 in Review

HighTower Advisors sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q4 2022, closing a stake of 35,560 shares — an estimated $355K sold.

HighTower Advisors first reported a position in MSAC in Q2 2021 and held it in 6 quarters. The position peaked at $397K in Q1 2022. 49 funds tracked by Wall St. Rank hold MSAC as of Q4 2022.

HighTower Advisors reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
HighTower Advisors sold 35,560 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q4 2022, an estimated $355K.
HighTower Advisors first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 6 quarters.
HighTower Advisors's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $397K in Q1 2022.
49 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.